Molecular cloning of wild-type and mutant osterix and its post-translational modifications in 293 cells by Ehrenman, Jason Scott
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations GSDM: Historical Theses and Dissertations (Open Access)
2014
Molecular cloning of wild-type and
mutant osterix and its
post-translational modifications in
293 cells
https://hdl.handle.net/2144/31800
Boston University
BOSTON UNIVERSITY
HENRY M. GOLDMAN SCHOOL OF DENTAL MEDICINE
THES重S
MOLECULAR CLONING OF WILD-TYPE AND MUTANT OSTERIX AND ITS
POST_TRANSLATIONAL MODIFICATIONS IN 293 CELLS
JASON SCOTT EHRENMAN
Doctor of Dental Medicine (D.M.D), University ofFIorida College ofDentistry, 201 1
Bachelor of Science (B.S), University ofFIorida, 2006
Submitted in partial餌甜1ment ofthe requlrementS for the degree of
Masters of Science in Dentistry
In the Department ofPeriodontoIogy and Oral BioIogy
2014
Boston University 
Copyright and Digitization Notice 
 
Copyright of this work is held by the author. 
This work is protected against unauthorized copying under Title 17, United States code. 
This reproduction is made available for personal use, and is not for distribution.  
 
The image quality of this digital reproduction depends on the quality of the print original. Signatures and 
personal information, if present, have been redacted. 
 
?? ?
???
Approved by:
Dr. Yoshiyuki Mochida, DDS, Ph.D.
Associate Professor
Department of PeriodontoIogy and Oral BioIogy
Second
Reader
Professor, Director of Oral BioIogy Research
Department of PeriodontoIogy and Oral BioIogy
Date互生
Dr. Serge Dibart, DMD
Chair of PeriodontoIogy & Oral BioIogy, Director ofthe Advanced
Specialty Education Program in Periodontics at GSDM’Professor
Dedication
This thesis is dedicated to my loving and supportive family who has been there
for me since the begiming ofmy long, arduous’and rewarding academic career. I must
particularly express my gratitude to my parents Dr. Michael and Adrieme Ehrenman for
keeping me gomg emOtionally and financially through all of my schooling. Dad’yOu
have always been a role model to me for how I want to practice and be respected by both
patients and colleagues・ Mom’yOu have been there countless times to give me your sage
advice, and to listen to me vent when I had a bad day. Special thanks go to my sister
Brittany for being my best飾end and helping to keep me grounded in reality. Brittany,
I’m so proud ofall the hard work and determination that you have put into your own
education; I wish I were halfas dedicated as you are・ I hope we both have many
e巾oyable and success餌years ofpractice in our respective careers. I Iove you all・
間
Acknowledgments
I would like to express my gratitude to Dr・ Serge Dibart D・M・D and Dr. Frank
Oppenheim D.D・S.’Ph・D., for providing me with the oppo血nity to餌her my education
into the field of PeriodontoIogy and Oral BioIogy・
I had the honor and pleasure of leammg under the instruction of Dr・ Mochida
D.D.S., Ph.D. this past year, the way in which he treats everyone who works with him
with such respect is a positive motivation and inspiration for everyone in the lab. Dr.
Mochida’s Iove ofscience and teaching is exceptional and a11owed me to e互ioy the
research process. I would like to express my thanks for the outstanding guidance he
provided with my pr句ect and his assistance with completing this thesis.
This year would have been very di餓cult if it were not for the assistance ofDr.
Yoshio Ohyama D.D・S., Ph・D・, in the lab. He is one ofthe most patient and generous
people I have ever had the pleasure to work with・ I would like to say thanks to Dr.
Ohyama for the answering the countless questions regarding laboratory technique that I
asked him, and for all the time he invested in teaching me how to be an effective
researcher.
I would also like to express my gratitude to Dr. Philip Trackman, Ph.D for his
time reviewing this thesis. His time spent reviewing this thesis was grate餌Iy accepted
on the path to making this thesis the best that it could be.
1V
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POST_TRANSLATIONAL MODIFICATIONS IN 293 CELLS
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ABSTRACT
Bone is one ofthe most important tissues in the human body, it gives both fom
and function and any abnormalities can have significant and detrimental effects. This is
why it is important to understand how the body triggers and regulates bone growth, SO
that we may understand where these abnomalities might occur, and possibly even treat
them. One ofthe most important regulatory controIs for bone fomation is the
Osterix/SP7 (Osx) gene, a Zinc finger motif containing transcription factor found in
osteoblasts. It has been found that in Osterix null mice, they are limited to creating
ca皿aginous tissue but camot create bone. The aims ofthis study are to identify ways in
which ce11s post-tranSlationally modfty the Osterix protein to further regulate its activity’
specifica11y by phosphorylation and ubiquitination. Mutant foms ofwild type (WT) Osx
were created by PCR that deleted each ofthe three zinc fingers (ZF3, ZF2, and ZFl) were
inserted into pcDNA3-FLAG tagged vectors. Another mutant form (K41R) was created
replacing the lysine-41 with arginine to prevent ubiquitination from occurring to see if
this apparent molecular weight gain could be prevented・ Transfection and overexpression
Ⅴ
ofthe wild type and mutant forms into human 293 cells demonstrated, after phosphatase
treatment, that the Osx protein is phosphorylated intrace11ularly’but that the protein still
has a molecular weight greater than the 46 kDa predicted by the number of amino acids.
Westem blotting to identify ubiquitination of lysine-4 1 was inconclusive because the
Osx_ZFl and Osx-ZFl-K41 R foms both had identical weights. Since the mono-
ubiquitination oflysine-41 has previously been shown, it is likely that the cell lineage or
experimental technique interferes with the ubiquitination ofthe protein. The human
Osterix gene clearly undergoes multiple post-tranSlational mod縦cations in-Vivo and
requires further study.
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1. INTRODUCTION
The human body is composed of many tissues cooperating to provide structure and
function to the overall organism・ One ofthese tissues is bone. Bone is a material
consisting of dense’mineralized’COnneCtive tissues allowing it to perfom specialized
functions that are unlque Only to bone・ Due to the density and rigidity ofbone, it
provides protection to intemal organs and anchorage for muscles in order to create
movement. The mineralization ofbone allows it to sequester minerals such as calcium
and phosphorous and release them when blood levels are low to maintain normal
homeostasis. Bones also capture toxic elements such as lead, and remove them from the
Circulation (Steele 1988).
エ臆.臆1臆Composition of BQpe
The hardness of bone lS ProVided by the high degree ofmineralization of its structure
which provides it with its unlque Characteristics・ Bone is approximately -70% mineral
content, -25% organic molecules, -5% water’and <3% lipids・ Ofthe organic
component, nearly all the molecules (-90%) are collagen as opposed lO% ofmost soft
tissues in the body. The remaining lO% ofthe organic molecules in bone consists of
non葛COllagenous molecules・ These non-CO11agenous molecules consist of growth factors
such as Bone Moxphogenetic Protein (BMP) and Transfoming Growth Factor-β (TGF-
P), bone specific extra-Cellular matrix proteins such as osteocalcin and RGD containing
glycoproteins, Serum PrOteins such as albumin’and proteoglycans (Young 2003).
1
The outer layer of bone consists of a dense area called cortical (Or COmPaCt) bone.
The imer layer of bone contains the much more porous trabecular (Or CanCellous) bone・
During the formation of cance11ous bone, OSteOblasts lay down osteoid, the non-
mineralized newly synthesized bone. When the osteoid becomes mineralized into
carbonated hydroxyapatite (CalO(PO4)6(OH)2), SOme OSteOblasts become trapped within the
bone and become osteocytes. In general’the predominant fom ofco11agen present in
bone matrix is Type I collagen (Bertazzo 2006).
1.2 DeveIoDment OfBone
Bone is formed by two distinct mechanisms: endochondral and intramembranous
oss描cation. Endochondral oss綿cation is the method used to form most ofthe bones of
the body, Particularly the long bones. When a bone develops via endochondral
ossification, it begins as a hyaline cartilage model ofthe bone, then starts to mineralize at
a prlmary OSS綿cation center. As the bone develops, SeCOndary ossification sites, known
as the epiphyseal plates’fom at the ends ofthe bone and allow for growth in a
lengthwise direction. Intramembraneous bone oss綿cation foms mainly the flat
craniofacial bones ofthe skull, the mandible, and the maxilla. These bones form directly
from mesenchymal condensations where osteoblasts differentiate from mesychemal stem
cells. These stem cells are slgnaled by several transcription factors and signaling proteins
such as: Indian hedgehog, Runx2, and Osterix (Tang, Yang et al・ 201 1).
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l.3 Osterix and its Role in Bone Formation
Endochondral and intramembranous ossification both require Runx2 to
di舐鵜ntiate mesenchymal ce11s into preosteoblasts. Osterix (SP7) is a transcription
factor gene that is presumed to be transcriptionally downstream ofRunx2 and is
particularly expressed in osteoblasts as well as in low levels in prehypertrophic
chondrocytes・ Osterix first appears in differentiating chondrocytes’Perichondrium, and
the mesenchymal condensations of餌ure membranous bones ofmouse embryos. Osterix
is also expressed highly in cells that are associated with trabecular bone and bone co11ar
formation (Tang, Yang et al. 201 1).
The human Osterix (Osx) gene, also known as Specificity Protein 7 (SP7), is a
novel zinc finger containing transcription factor that is expressed in all developing bones・
Osterix is not only found in osteoblasts’but is essential for their differentiation,
proliferation, and bone fomation (Ohyama, Katafuchi et al. 2012). The Osterix protein
is a 428 amino acid polypeptide with a molecular mass ofapproximately 46 kDa. The
DNA binding domain of Osterix is found at the C-teminus and contains three C2H2 type
zinc finger domains that have a large degree of similarity with the related moti烏found in
Spl, Sp3 and Sp4. The Osterix protein has been shown to be responsible for regulating
the expression of many lmPOrtant OSteOblast markers of di鮎鵬ntiation such as:
osteonectin, OSteOPOntin, OSteOCalcin, and alkaline phosphatase in non-OSSeOuS C2C 1 2
myoblasts. Osterix has been shown to be a a positive transcriptional regulator of
osteoblast differentiation (Choi, Gu et al. 201 1).
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It has been shown that in a mouse model deficient in the Osterix gene, nO bone is
formed at all. In these Osx nu11 mice, during endochondral skeletal development the
meseynchymal ce11s combined with osteoclasts and blood vessels invade the mineralized
cartilage matrix, but the mesynchymal cells do not deposit bone matrix. Additionally’
periosteum and condensed mesynchyme of the intramembraneous bones can not
di塙鵜ntiate into oseoblasts without expressing Osterix. These Osx null cells still express
Runx2/Cbfal, Which is normally required for bone formation・ However’ifthe
Runx2/Cbfalgene is inhibited and the Osterix gene is nomal’the Osterix gene is not
expressed. Thus, Osterix was demonstrated to be expressed downstream of Runx2/Cbfal
(Nakashima, Zhou et al. 2002).
Osteogenesis imperfecta has also been linked to mutations in the Osterix gene。
Osteogenesis imperfecta (OI) is a genetically heritable bone-related disorder with wide
variety in presentation and severity, but typically resulting in low bone mass and fragile
bones. In some patients there are additional symptoms displayed, SuCh as blue sclera’
delayed tooth eruption and/or tooth development abnomalities, and impaired hearing
(Sillence, Sem et al. 1979). These symptoms are all related to problems with type I
collagen fomation, in which a base pair deletion (C.1052delA) in Osterix has been
identified (Lapunzina, Aglan et al. 201 0).
1.4 Post-tranSIational Modi鮭cation
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Once a protein is translated, its functions may be modulated by a process known
as post-tranSlational modification. Post-tranSlational modification is the biochemical
alteration of a protein following translation that occurs intra-Cellularly. While there are
many types ofmodifications that may occur on a protein, this thesis will be limited to a
discussion of phosphorylation and ubiquitination. Phosphorylation refers to the process
of adding a phosphate group (PO43-) to particular amino acids, SuCh as: Serine, threonine
and tyrosine. Kinases are enzymes that add phosphate groups, and phosphatases are the
enzmes that remove the phosphate from a target protein. The process ofphosphorylation
as a mechanism for regulating phsygioIogical processes was initially discovered by Eddie
Fischer and Ed Krebs, in 1955. They found that the the activation ofglycogen
phospohorylase from it’s ``b" fom to its寝a" form required a protein kinase’and calcium.
Kinases and phosphatases can control the function of a protein in a large variety ofways’
by stabilizing it, marking it for disposal, increasing/decreasing its activity’blocking it
from movement between intracellular compartments, and directing protein-PrOtein
interactions. The reversible nature ofphosphorylation as well as its rapid availability,
due to ATP as a phoshoryl donor, makes it one ofthe most powerful physioIogic
regulators in eukaryotic bioIogy・
The addition or subtraction of a phosphate group to a protein causes
confomational changes to the protein that can either be activated or deactivated・ For
example, Osterix has been shown to be phosphorylated by the extracellular signal-
regulated protein kinases l and 2 (ERK l & 2), Ofthe mitogen-aCtivated protein kinase
super family (MAPK). It has been shown that the Erkl/2 kinases act to stabilize the
与
Osterix protein intracellularly through the addition of phosphate intracellularly (Choi, Gu
etal. 2011).
Ubiquitin is itselfa small, 8 kDa regulatory protein that is found in almost a11
eukaryotic tissues and is covalently attached to lysine residues in target proteins. Where
Phosphorylation causes a confomational change in the protein, ubiquitination of a
PrOtein causes a variety ofpossible results. The ubiquitination process adds either a
Single ubiquitin molecule to the lysine, mOnO-ubiquitination, Or a POly-ubiquitin chain
may be formed (AIpi, Pace et al. 2008). Additiona11y, SeVeral lysine residues within the
Same PrOtein can be tagged with ubiquitin, referred to as multiubiquitination. The mono-
ubiquitination of a protein can slgnal several di餓ifent things; it may mark transmembrane
PrOteins in vesicles for lysosomal degradation, it can mark a protein for breakdown in the
PrOteaSOme, it may help with the sorting ofvacuoles following endocytosis. There have
also been findings demonstrating that ubiquitination has a role in DNA repalr and
transcriptional regulation by modification of histones and transcription factors (Haglund
and Dikic 2005).
The ubiquitine protein itself contains seven lysine residues, all ofwhich are
POSSibly invoIved in fommg POly-ubiquitine chains. Similar to phosphorylation,
ubiquitination is reversible and can be quickly removed by deubiquitinating enzymes
(DUBs). The poly-ubiquitination of lysine is considered as a classical tagging ofa
PrOtein for destruction in the proteasome (Ikeda and Dikic 2008). It has become clear
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that while it may not be obligatory, it appears that phosphorylation often precedes
ubiquitination of a protein (Haglund and Dikic 2005).
2. HYPOTHESIS
Based on the experimental data perfomed in our laboratory’the molecular weight
of Osterix protein determined by Westem blotting appears slightly higher than the one
predicted by amino acid numbers. Our hypothesis is that the Osterix protein undergoes
post-tranSlational modification’SPeCifically phosphorylation or ubiquitination of the
PrOtein.
2.1 OBJECTIVES
1) To cIone and express the three mutant foms ofOsterix (ZFl, ZF2, & ZF3) in
a mammalian cell line.
2) To de-Phosphorylate the Osterix protein in order to verify the presence of a
Pho sphate.
3) To identify the presence ofan ubiquitinated lysine-41 in the Osterix protein by
mutating it into an arginine that camot be ubiquitinated
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3. MATERIALS AND METHODS
3.1 Rea箪entS
Oligonucleotides were synthesized and obtained from Eurofins MWG Operon
(Huntsville, AL, USA). For polymerase chain reaction, HotStar HiFidelity Polymerase
Kit (HotStar HiFidelity DNA Polymerase, 5x HotStar HiFidelity PCR Buffer, 5Ⅹ Q-
Solution) was purchased from Qiagen (Valencia, CA, USA)・ For PCR product
purification, Wizard⑧ PCR Preps DNA Pu揃cation System kit was purchased from
Promega (Madison, WI, USA). Restriction endonucleases, EcoRI, XhoI, and XmaI were
purchased from New England Biolabs (Ipswich, MA, USA). Agarose, Lysogeny broth
(LB) miller, and LB agar miller were purchased from Fisher scien揃c (Pittsburg, PA,
USA). For gel extraction, QIAquick Gel Extraction Kit was purchased from Qiagen. T4
DNA Ligase was purchased from New England Biolabs・ JMl O9 Competent Cells were
purchased from Promega. Plasmid miniprep was prepared using QIAprep Spin Miniprep
Kit purchased from Qiagen. Plasmid midiprep was prepared using QIAGEN Plasmid
Midi Kit purchased from Qiagen. Qproteome Nuclear Protein Kit was purchased from
Quiagen. Human embryonic kidney 293 cells were purchased from CIontech. Dulbecco-s
Mod誼ied Eagle Medium (DMEM) (1X), 1iquid (high glucose) was purchased from
Invitrogen (Carlsbad, CA, USA). Penicillin-Streptomycin Solution, 1 00X (10,000 I.U.-
Penicillin, Streptomycin-1 0,000 Hg/mL) was purchased from Mediatech, Inc. (Manassas,
VA., USA). Fetal Bovine Serum was purchased from Invitrogen・ Trypsin, 0.25% 1X,
with 2.5g porcine trypsin (1 :250/L gamma irradiated) in HBSS with lg几EDTA, Without
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calcium, magneSium (liquid) purchased from Themo Scien捕c (Waltham, MA, USA)・
Radioimmunoprecipitation assay buffer (RTPA buffer) containing 50 mM, Tris-HCI pH
8.0, 150 mM NaCl, 0.1 % SDS, 0.5 % deoxycholate, and l%NP-40 was used. Halt
phosphatase inhibitor cocktail was purchased from Themo Scien描c. ANTI-FLAG⑱
M2 A綿nity Gel pu捕ed immunoglobulin; bu節ered aqueous glyceroI solution and
FLAG-PePtide were purchased from Sigma-Aldrich (St・ Louis, MO, USA)・ MonocIonal
ANTI-FLAG⑱ M2 antibody produced in mouse, IgGl , WaS PurChased from Sigma-
Aldrich. Goat Anti-Mouse IgG (H+L), alkaline phosphatase co互iugated and ImmunoPure
Goat Anti-Rabbit IgG (H+L), alkaline phosphatase co可ugated were purchased from
Themo Scientific. SDS NuPAGE⑱ MOPS SDS Ruming Buffer (for Bis-Tris Gels only)
(20X) was purchased from Invitrogen. NuPAGE⑱ Novex 4-12% Bis-Tris Ge1 1.O mm,
12 well was purchased from Invitrogen・ Immobilon-P Membrane was purchased from
Millipore (Bi11erica, MA, USA). Transfer buffer containing (0.025M Tris-HCl, 0.192M
glycine, and 20% methanol) was used. Nonfat dry milk was purchased from Lab
Scientific (Livingston, NJ, USA). Alkaline phosphatase ’co互iugate substrate kit was
purchased from Bio-Rad laboratories (Hercules, CA, USA). Lamba protein phosphatase,
NEBuffer for PMP, and lOmM Mn Chloride for PMP was purchased from New England
Biolabs.
3.2 Generation of Osterix/SP7 (OSX) DeletionlMutation Constructs in a
Mammalian Expression System
The wild type Osterix and the first zinc finger deletion (ZF3) fom were already
available in our laboratory. The Osterix-ZF3 mutant is derived from the wild type fom
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of Osterix but with the third zinc finger mutated causlng a Premature StOP COdon that
prevents proper coding for the third zinc finger’instead by 1 8 extraneous amino acids.
The same mutation found in ZF3 has been reported to be present in Osteogenesis
imperfecta type XI (Lapunzina, Aglan et al. 2010)・ Both sequences ofplasmids were
verified through the National Center for BiotechnoIogy Infomation OVCBI) Reference
Sequence: NM 152860.1. The first mutant that needed to be created was the deletion of
the second zinc finger (ZF2). Using the Osterix gene as a template, tWO CuStOm Primers
were created to selectively amplify the gene by Polymerase Chain Reaction (PCR)
method. The EcoRI置F primer was 29 base-PalrS, Which had 21 bp’s from the Osterix
gene and initiates with the EcoRT site. The XhoI-R primer also has 29 bp’s, W皿18
coding bp’s originating from the wild type Osterix (Figure l l). The XhoI-R primer
introduces an early stop codon followed by the XhoI cleavage site immediately before the
first Phenylalanine ofthe second Zinc finger・ PCR was then used to amplify the Osx-
ZF2 using the wild type Osterix as the template. PCR was perfomed with the Hot Star
PCRprotocoI of: 95Oc for 5 mins. (1 cycle), at 94Oc for 15 sec., at 60Oc for l min・, at 72
Oc for 45 sec. (30 cycles) and at 72Oc for lO min・ (1 cycle)・ Additionally, anOther mutant
fom with the first zinc finger (ZFl) was deleted created in the same mamer as ZF2 using
the primer XhoI-Osx-ZFl-R (Figure l l). The PCR products were pu揃ed using the
Wizard⑱ PCR Preps DNA Purification System according to the manufacturer’s
instructions and then digested using EcoRI and XhoI restriction enzymes・ The digested
PCR products were collected using the QIAquick Gel Extraction Kit from the agarose gel
electrophoresis. The collected DNA segments were ligated to pcDNA3-FLAG tagged
vector, PreViously digested with EcoRT伏hoI, in T4 DNA ligase buffer using T4 DNA
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ligase. The mixture was incubated ovemight at room temperature・ The ligated plasmids
Were then transfomed to lOO HL ofhighly e綿cient JMlO9 E.Coli ce11s and allowed to
rest for 30 minutes on ice. The JMlO9 and plasmids were then heat shocked for 40
SeCOnds at 42Oc and placed for 2 minutes on ice. Two hundred HL ofLB medium was
added to the transfomed bacteria. The mixture was then incubated for l hour at 37 Oc,
and afterwards the cultures were plated onto LB agar plates containing ampici11in and
incubated ovemight at 37 Oc. several coIonies were selected from each plate and placed
in 2mL ofLB broth with ampicillin to incubate ovemight at 37 Oc.The plasmids were
then recovered from the bacteria cultures using the QIAprep Spin Miniprep Kit and
Subsequently digested with the EcoRT and XhoI restriction enzymes. The presence ofthe
PCR products was ver描ed through agarose gel electrophoresis. When the specific
bacterial coIonies containing the correct DNA inserts were identified, they were cultured
in large volumes ofLB broth with ampicillin ovemight at 37 Oc. These large cultures
Were then used to co11ect plasmids using QIAGEN Plasmid Midi Kit. The inserts ofOsx-
ZF2 and Osx-ZFI were then sequenced and compared to NCBI reference sequence
NM 1 52860.1. The results d6monstrated lOO% identity and ver綿ed that the mutant
foms of Osx were correctly const則Cted.
3.3 CeII Culture, Transfection. ImmunoDreCiDitation and Western BIotting Analvsis
Human embryonic kidney 293 ce11s were prepared in high-glucose (4.5 mg/mL)
DMEM to which lO% fetal bovine serum, 100 units/mL and lOO Hg/ml streptomycm
Were added. The cells were incubated in a 5% CO2 atmOSPhere at 37 Oc for the duration
Of the experiment.
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First, the 293 cells were plated onto 6-Well culture plates at a concentration of 2.5
x lO5 cells per well. On the fo11owing day, the cells were transiently transfected using the
X-tremeGENE 9 DNA transfection reagent. The cells were transfected with the empty
PCDNA3-FLAG vector (EV), the vector containing the wild type Osterix gene pcDNA3-
FLAG-WT-OSX (WT), and the three mutant foms of Osterix with the teminal, middle,
and first zinc finger site deleted respectively: PCDNA3-FLAG-ZF3-OSX (Osx-ZF3),
pcDNA3-FLAG-ZF2-OSX (Osx-ZF2), PCDNA3-FLAG-ZFl-OSX (Osx-ZF l ). After the
transfected cells were incubated for 48 hours, they were lysed using RTPA buffer. The
lysate was centr胤ged and the supematant was then collected. Fifteen uL of anti-
FLAG⑱ M2 A縦nity Gel (M2 gel) was added to each lysate and they were agitated for
lO minutes at 4 Oc・ The samples were centrifuged, the supematant was discarded and the
M2 gel was washed twice with fresh RTPA buffer. After the final wash, the sample for
immunoprecipitation was centrifuged’the supematant of RTPA buffer was discarded, and
the proteins of interest were eluted from the M2 gel by rinsing the gel with Flag peptide
solution and agitating it for 5 minutes. Finally’the samples were centrifuged, the
supematant was co11ected and incubated with SDS-PAGE sample bu飾if (100 mM Tris-
HCl, PH 8.8, 0.01% bromphenol blue, 36% glycerol, 4% SDS) for 5 minutes at room
temperature. Samples were then applied to the SDS-POlyacrylamide gel (SDS-PAGE)
using NuPAGE⑱ Novex⑱ 4-12% Bis-Tris Gels. The samples were then transferred to
Immobilon-P Membrane in transfer bu鮮訂containing O.025M Tris-HCl, 0.192M glycine,
and 20% methanol using Mini-PROTEAN㊥ Tetra Cell system ovemight at 30 volts and
O.04 amperes (Mochida, Parisuthiman et al. 2006). The membrane was blocked with
TBS (20 mM Tris-HCl, PH 7.5, 137 nM NaCl) containing 10% skim milk ovemight at
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4Oc. The next day, the membrane was washed 3 times with TBS-T and once with TBS
(20 mM Tris-HCL, PH 7.5, 137 nM NaCl, 0.1% tween). Then the membrane was
incubated with monocIonal anti-FLAG antibody (1 : 1 000 dilution) ovemight at 4 Oc.
Again, the membrane was washed 3 times with TBS, and once with TBS-T, then the
membrane was incubated with O.01 % anti-mOuSe antibody for one hour at room
temperature. The membrane was washed 3 times with TBS-T and once with TBS, and
then visualized using the alkaline phosphatase cor可gate substrate kit.
3.4 Generatio町Of Osx-ZF宣-K41R Mutation and Western BIottin
As shown in Figure lO, the Osx-ZFl-K41R mutant fom is the same as the Osx-
ZFl mutant except that the lysine-41 (aaa) is mutated to an arginine (agg). As such, tO
generate the Osx-ZFl -K41R mutant, Wild type Osterix was used as the template during
PCR. Two segments, a long strand and a short strand, Were Created and then joined
together during PCR to create the new mutant (Figure lO). The short segment cycle used
the EcoRI-Osx-F primer and the new Osx-K41R-R primer to create the segment labeled
寝1" in Figure lO. The long strand, labeled寝2,, was created by using the new Osx-K41R-
F primer and the XhoトOsx-ZFl-R primer. Both reactions were performed under the Hot
Star protocol in the same manner as described in section 3.2・ These two processes
Created segments that represent the beginning segment that ends just past the two point
mutations, and a long segment that begins just before the mutations, thus creating an
OVerlap・ Only the long segment product was pur綿ed using the Wizard㊥ PCR Preps
DNA Purification System due to the risk of losing the much smaller short segment during
Purification. Next, uSing the purified long segment and the short segment as templates
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for each other, the original Osx-ZFI primers (EcoRT-Osx-F and XhoI-Osx-ZFl -R) were
used in a final PCR cycle to join the segments and create copleS Ofthe complete mutant.
This product was then purified using the Wizard⑱ PCR Preps DNA Purification System
and collected from agarose gel electrophoresis as in the previous steps・
The Osx-ZFl -K41R segment was digested with EcoRT/XhoI, incubated ovemight
at room temperature, and transfomed to highly e縦cient JMlO9 E. Coli cells. As in
section 3.3, the bacteria were grown in LB medium containing ampici11in ovemight. The
next day the media was plated on LB agar plates with ampicillin and incubated ovemight.
Four coIonies were selected, and the plasmids recovered using the QIAprep Spin
Miniprep Kit and digested with EcoRT and XhoI restriction enzymes. The presence of
the correct PCR product was verified by agarose gel electrophoresis in one ofthe
coIonies. The insert was also sequenced and verified against the NCBI reference
NM 1 52860.1 showing lOO% identity except for the two newly created point mutations.
This coIony was selected and incubated in a larger volume ofmedia to be fu血er
co11ected and purified using the QIAGEN Plasmid Midi Kit・
Using the collected Osx-ZFl -K41 R plasmids’293 ce11s were again transiently
transfected and incubated ovemight・ Additionally, 293 cells were transfected w皿Osx-
ZFl as we11 as the empty pcDNA3-FLAG vector as a control・ The cells were then lysed
with RTPA buffer and the lysate was pur綿ed, immunoprecipitated, and Westem blotting
was performed in the same mamer described above. The results are shown in Figure 9・
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4. RESULTS
4.1 PreDaration of Osx-ZFl and Osx-ZF2 Mutant Vectors
The ZF3 fom was constructed in a mammalian expression vector in a previous
experiment in which the third zinc finger was deleted from the wild type Osterix gene.
The Osx-ZFl and Osx-ZF2 foms were created to delete the lSt and 2nd zinc fingers
respectively by means ofPCR method (Figure l). A trial PCR run was perfomed using
two variations ofthe same protocol, the first with increased amount oftemplate and the
second with increased amount of primers. The results were then confirmed by DNA
electrophoresis (Figure 2). As the condition where the amount ofprimers was increased
(Figure 2, lanes 3 & 4) seemed to be successful, PCR reaction was perfomed by this
condition and the PCR products were co=ected using the gel extraction technique after
the enzymatic digestion with EcoRI and XhoI (Figure 3)・
The gel extraction products of Osx-ZFl and Osx-ZF2 were ligated to the pc3-
5’Flag vector digested with EcoRI/XhoI and the ligated samples were subsequently
transfomed to the high competency JMlO9 E. Coli bacterial strain・ The transfomed
JMlO9 bacteria were plated and cultured ovemight. Five coIonies from each type of
construct, i.e. Osx-ZF l and Osx-ZF2, Were Cultured and the plasmid DNAs were isolated
using Mini-Prep・ The plasmids were digested with EcoRT/XhoI separated by gel
electrophoresis (Figure 4) to check for presence ofthe correct inserL Lane/coIony “A”
was selected for both Osx-ZFl and Osx-ZF2 out ofa potential of5 and 4 viable coIonies,
1与
respectively. The selected coIonies were then cultured in 250 mL ofLB broth with
ampici11in for 48 hours and the plasmids were isolated via MIDI prep and diluted to
l唯/mL. The plasmids were sequenced and compared to NCBI database’NP_690599.1
to verify lOO% accuracy.
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A. Protein Sequence ofOsterix (Wild Type)
10　　　　　　20　　　　　　30　　　　　　40　　　　　　与0　　　　　　60
MASSLLEEEV HYGSSPLAML TAACSKFGGS SPLRDSTTLG KAGTKKPYSV GSDLSASKTM
70　　　　　　80　　　　　　90　　　　　100　　　　　110　　　　　120
GDAYPAPFTS TNGLLSPAGS PPAPTSGYAN DYPPFSHSFP GPTG冒QDPGI LVPKGHSSSD
130　　　　　140　　　　　150　　　　　160　　　　　170　　　　　180
CLPSVYTSLD MTHPYGSWYK AG工HAG工SPG PGNTP冒PWWD MHPGGNWIJGG GQGQGDGLQG
190　　　　　200　　　　　210　　　　　220　　　　　230　　　　　240
TLPでGPAQPP LNPQLPTYPS DFAPLNPAPY PAPHLLQPGP QHVLPQDVYK PKAVGNSGQL
2与0　　　　　260　　　　　27o　　　　　280　　　　　290　　　　　300
EGSGGAKPPR GASTGGSGGY GGSGAGRSSC DCPNCQ珊ER LGAAAAGLRK∴KP工…三三三
310　　　　　320　　　　　330　　　　　340　　　　　350　　　　　360
R雷KK=三三三
370　　　　　380　　　　　390　　　　　400　　　　　410　　　　　420
二3EPG PGPPPSGPKE LGEGRSTGEE　且ASQでPRPSA SPATPEKAPG
430
B. Nuc萱eotide & Protein Sequence of Second Zinc Fi∴唯er Deletion Form (ZF2
ま23　、 ‾↑9c9きき雪もccg亡きcもち留年9雪a曾gaaくゆきc己Ctaちq曙cちcc己らち
○○　鼻　S S　裏　巳　E　雷　雪　V　麗　甘　露∴S S
1さS cccきち的cc　く　ct9種c襲ca9cく重きca9Cきaatこも99エ9ec亡C亡
P　さ　ま　　　と　工　亀　ふ　き　S　轍　『　G∴G S
2i 3　己曾ec雪亡cき3きり割さaききcaまc種actCC曾9雷電す亀種曾Ca99c種c年aa9
S P∴己∴R∴D∴S∴T　了　重∴∴G∴iく　え　G　了∴轍
2る8　aaきcC軒aCtcちら軍容胃cc種容C寄accきち亡caeccエきCaaa亀cc　置
欝　胃　で　S V　露∴S D　巳∴S∴ふ∴S∴欝　で
3o 3 99割夢種も○○eちatCCa富CcccCtttacきa9cacこ種aC9e9cちcCtC
G D　え　7　?　主　審　『　了　S　了　鄭　雪　L∴∴L
3モき　ちc亀cc章9c種99き種〇年ccち雷ca9cacC雪aき∝ca99C亡己ちぢceaaち
S P　ゑ　馨　S p P　亀　雷∴了　S　容∴Y∴A∴蜘
393　gaきちacc雪もccきちも耽CccaCじCaきち∝C亡脅9gcCcac種留年cさCC
D∴音曹　P　雷∴F∴S∴∴鼠　S　『∴P∴G∴雷∴T∴∴G　工
事3 8　ca抑aeccち雪雪9cきa雪章a9t事ccca種g曾g書きaca9ctC亡きC章9ac
嚢　D P G　己　も　V　審　議　さ∴擁　S S S∴寄
亀容3　きりtCC9cCC寄留も9tCちa嚢accちc章cき卿aC acac己ごcC亡きat
C　乙　P S　廿　甘　T S L D T　東　雷∴ず
ら2合　99c章ccte軒aCaa99ca99c己きCきaち9Ca99caきちCcacCa99c
G S　構　曽　費　え　G　エ　穏　A G　基　S P∴さ
ら73　cca99caacaきちc雪もacちcCae言直9事9aし‾‾　cきccCきき9a99c
さ　さ　前　軍　曹　で　手　鞠　靖　D　　　欝∴∴P∴∴G∴∴さ
ら亀e a種きち99cちa9〇年9事七曾99ca富ざらCc亀999き亭a章○○9cC9Ca亀雷的
前　討　ち　6　雷　電　合　さ　Q∴G D G∴も∴露∴毎
`63 acacき曾ccき年雪a99tきC寄曾ctca9CC曾cGすcちらaaeccCc裏9ce9
重　し　雷　で　雪　?　A　響　P P　己　的　雷　露　暮
てoe cccac書き轟c雷電書きcち9aC亡きも9きちCccc亡き裏年ききCa9CccCctac
P∴了∴r∴P∴S D　『　鼻　雷　と　前　審　鼻　胃　で
てる3　ccagcきcc年ca雪cききらち9caacca99容CccきagCaち雪も⊂こき胃ccc
P A P　覚　重　己　賓　P G P　露　盤　や　暮∴雷
?9e ca寄りa均C c亡aちaa亀ccC年a靭cささ匹g99aaaもa曾C999きaきc亡a
嚢　D　吋　で　賞　さ　呈く　ゑ　V G∴討　S G∴蜜　し
純3　9aa9ggき9C○○C9g種9ccaaaccccCac99曾9Cqc亀種9Cacき99曾
雷　G S G　さ　え　貰　さ　P　鼠　G A S　で∴G
eS亀　9g亡a容も99亡99aCat9○○gsCa曾亡○○留言Ca999c9cCcききcct9c
G S G　毒　甘　さ　G S　雪　Å　G　鼠　S S C
93 3 9ac亡9cCcきaa章もgcCag9a9cCa9寄曾cg9Ctさ曙ga9ca事caec嘗
寄∴C∴ど∴N∴C∴響　E　し　雷　員∴暮∴G∴え∴Å∴亀
9了さ　9 C99gc 曾ce9aagaa9ccc亀C ccaca曾cち9CCaca亡Ccct9gc
亀　G　暮　京　轍　薫　2　基　盤∴S C　鰻　重　P G
二〇23　ち c○○caa9きき露aき99caま9○○らちc年CaCcき9aagoCCcきcC亡9
C s　議　や　Y G　轍　鼻　S　韓　と　貰　亀　嵩　し
ま寄69　き9 ち99cacaca99⊂導a9aきeccC亡もC§こC亡雪Caさ〇℃qqC亡C亡亡き
R　構音∴鵜∴∴で　G　量∴∴京音∴P F V∴C∴N∴鞠∴し　F
二二二3　亡ecg§Ca己9d郎声亡CaCこC9もちCq9aCqa°Ct9qa9C9亡Catqtq
C∴G∴轍∴鼠∴∴F T　鼠　S D∴王∴」∴雷∴員∴∴H V
二1S8　c9C ctCaCaC⊂⊂q99a9aa9aa〇℃こCaCCtqCCこqCtC七9CtCC
鼠　丁　擁　丁　員∴王: 】薫∴K∴∴F　丁　C∴∴し∴∴し∴∴C S
二203　aa°cq tt亡aCCCoaaqCqaCC種CC亡qa曾caaaCacCa9CqCaCC
鼠∴∴員∴F　工　員∴S D　擁∴乙　S　貰∴貰∴Q∴鼠　丁
二之4 8　cac〇°aqaaCCaq9CきC9qq亡cCCcCCCCCaq亡99CCCCaa90ae
轍∴∴G∴∴雷　P G∴∴P∴∴G P P P∴∴S∴∴5　P K E
二2 3　ct9qq9qa99qCC9CaqCaCg○○9qaa9a99ag9CCaq章Ca°aC9
L∴G E　き∴員　S　重∴G E E E　Å∴S∴Q∴T
二338　 c 9aCCこt C亡gCCtCqCC種9CaaCCCCaqaqaa種9CCCCCq9a
P∴員∴P S　Åi∴S P A T P　量　K A P∴き
二393 0qCag∝C巧さ°CaqaqCaaCC亡9Cこ的aqaきCt9a　二`18
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C. Nucleotide & Protein Sequence of First Zinc Fin箪eI.∴Deletion Form (ZFl
12 3　　ききゆききち雪さきも9雪も章脅ag寧a雪辱aa9きちCa雪こa亡g9∝ CCa9C
¥∴A∴S∴∴S　」　と∴E∴量∴∴雷　V　纂∴1′∴G S S
王6き　ccc雪き響9cc　+　ce9轟き寧富c書留C軒9ca9caaaももこ99き寄g雪もc亡
P　し　克　　　己　う　ふ　ふi∴C S　隷∴I「∴G∴∴雪　S
21 3 a9cきCきcち9c9拘acCCaaca寄cちc亡999G鶴亀a9ca99cさc己ささ9
5　雷　と　京　か　§　了　で　も　G　貰　え　G　重　賞
25s aa○○cg寄書きちきち9ち約〇ca9C曾acC亡亡きca胃cctccaa亀acc -
離　農　で　S V G∴∴S D I S　ふ　S　韓　で∴_
303 ○○雪9aちらcきちaきCca9ccきccらちもさC種a9GすCCaa亡e曾9cちccきち
$　D A Y p　鼻　書　手∴1富　S　了　的∴G∴己∴∴裏
3亀容　もc亀きき均〇年99雪種9tccちcCa9ca雷cc種cc亀ca胃9雪もaこ容cち亀aち
S p　ゑ　G S P P　鼻　P∴音軍　S s∴甘∴え∴討
393　留まじきacccececもちきちCcc種ききcaきち雪ccち9唇9cCc種C種99c寄cき
D　γ　P P　『　S　東　S　亨　P G　農　工∴iG　重
く3容　c書99aごcct9g曾雪Cac亡a雷も9雪c〇年ag9寄9cacさ曾ct cきち〇℃事ac
響　D P G　己　も　V　香　費　G　穏　S∴S S D
匂83　章骨もCち曾eceさgt智もきちacacc亡c亡cきg曙aC ∴ 「種CaCacccきちaこ
こ∴L∴g S V音ir　工　S　し　D　こ　　う　叢　P　ず
ら2 8　39c章cCち○○ち年Caa99ca9胃catcCaC9ca寄りcat亡きCacca寄曾C
G∴S∴輔∴Y∴髭　亀、 iさ　重　弟∴鼻i∴G I S P∴iG
513　cca99CaacacちCCききCtcc種もe軒9雪容at(　雷acc雪t胃きa99c
P G　討　す　農　で　P　鞘i i輔　D　、　東∴P∴G∴音G
6ユ9　a書cちら曾cこa9雷も99ち9g箪ca昏寧9cc種色町〇℃曾aち993cち9c種寄9靖
前　榊　も　G G　§　寄　6∴Q G D G∴乙∴蜜∴G
663 acac章9きcc種c寄○○もcca9c亡き種9Ccちcc亀Cきga種C雷cCca9ct9
曹∴∴エ∴p　重　電　P A　蜜　P　雷　」　的　P　露∴重
了o露　cccaccきa雷電catc亡9種cきち亡9cCCcccもちaa亡cc亀9きCccc章種C
P∴了∴Y∴P S D　『　ゑ　P　工　前　P　ふ　き　Y
憐3　ccaqcきcCcき種C雪もc亡き曾ごaaCc種999亡きcca8c曇も胃も雪きち9CCC
P　ふ　P　農　工　す　響　p G P　露　盤　V L∴亭
?9容　caa9aC9CCtaちらa種Cccaae9caきき99曾aaaCaらち999cagC亡a
蜜　D Vi　γ　隷　書　欝∴A V G∴前　S　さ∴蜜∴己
e亀3 9aa9ge寄9t○○Cg9a富cc書きaccCccaC寄句曙9珂caaecact○○富
雷　電　S　容　G A　薫　雷　P　鼠　G　亀　S　了∴∴G
合容e　寄りもaeC9きち9きaちa亡○○押9Cす曾C○○的Ca〇〇〇C9c亡ccもccきec
G S G∴G∴γ∴G∴音G S G∴.A G R S S∴∴C
93 3 9ac亡9ccCきaaきき9c∈ag9a9C章a曾a3ce9c亡9○○a9c種9c轟きC9
D C P　前　音き　く‡雷∴裏　書　鼠∴L G A∴A∴鼻
9?合9cCg胃9cC9c○○す亀9aa○○CcaじCCaCa雪鍵gCCaCaこC⊂C巧手C
ふ　さ　重　貫　轍　欝二∴P　重　賞∴∴S∴∴C∴∴貰　I P　3
1023　t曾Cq§Caa9官t官もaこ曾CCadq9C耽C雪CaCCじ富aa筆qCCCaCt亡き
こ　き　敦　す　ず　3　貰　え　S　麗　し　K　ふ　慕　L
Figure l: Protein and Nuc獲eotide Sequences of Osx-WT, ZF2. and ZFl
(A) Shows血e protein sequence ofthe wild type hunan Osterix gene and highlighted in
blue are血e locatious ofall three Zinc Fingers.
@) Shows血e sequence ofOsx-ZF2 with血e deleted second zinc紐1ger in red・
(C) Shows血e amino acid sequence, and corresponding nucleic acids, that were deleted
to create the Osx-ZFl mutation. The segment in red is血e upstream zinc finger血at was
deleted, and血e green highlighted region was血e previously deleted second zinc finger.
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A.
1 2　3　蜜
B.
芝F
1 2∵肇　芝
Figure 2: Tria獲PCR Low/Hi里h Primer Amounts
1芝　3　4
(A) Demonstrates four lanes. Lanes l and 3 are Osx-ZFl and lanes 2 and 4 are Osx-ZF2.
Lanes 3 & 4 showed significantly purer bands and so that was the protocoI chosen to
continue for the PCR (high primer amounts).
(B) Shows the same electrophoresis gel in its entirety including marker lane on the left.
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A.
ZFI Z戸芝
1　　　　芝
B.
Figure 3: Gel Extraction ofZFl and ZF2 Mutants
芝戸I　之F2
‾‾‾‾　　臆臆臆臆臆臆臆臆　　臆
(A) Demonstrates the gel electrophoresis that was used to extract the PCR products.
This image shows the half ofthe gel that was treated with Et-Br to confim the presence
ofthe correct bands and their location on the gel. The other half not shown, WaS uSed for
the gel extraction.
(B) Shows the originating electrophoresis gel. The marker lane is visible on the left side
Ofthegel.
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雪　空　霊　堂　裏　庭　官　爵　蜜1蹄
Figure 4: Se萱ection of Successful Transformed CoIonies
Five coIonies each were selected from Osx-ZF l and Osx-ZF2 bacterial culture plates.
The results demonstrated the bands representative of the appropriate size in bp for their
respective plasmids except from coIony D of Osx-ZF2. The molecular marker lane was
Shown on the left side ofthe gel.
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4.2 0verexDreSSion of Osterix Protein in Mammalian CeIIs
Human embryonic kidney 293 cells were cultured in DMEM and transfected with an
empty vector (PC3-5’Flag, EV), WT-Osx, Osx-ZF3, Osx-ZF2, Osx-ZFl in order to
verify the expression ofwild type and mutant forms ofthe Osterix proteins. The
resulting proteins were then collected by lysing the transfected cells with RTPA bu飾er.
The lysate was then immuno-PreCipitated using M2 Gel, the proteins were separated by
SDS-PAGE and Westem blot analysis was performed using anti-FLAG antibody (Figure
5).
A.
距腰部
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B.
距取却
巨V騨丁　之F
篭　壁∴1
1∴2∴塞∴蜜　5
IP: Anti-Flag (M2 Gel)
WB: Anti-Flag
Figure 5: ExDreSSion ofOsx-WT. ZF3. ZF2. & ZFI Proteins
(A) The expression of Osx-WT and three mutant foms of Osx was verified by the
immune-PreCipitation (IP) and Westem blot (WB) analysis. Note that in all four lanes
(Lanes 2-5), there appears to be three bands present.
(B) This figure is the source image for Figure 5a showing the entire membrane・
Molecular marker lanes are present on the left and right side ofthe membrane.
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4.3　PhosDhorvlation of Osterix Protein
As shown in Fig. 5, multiple bands are present by the expression ofany Osterix forms・
We speculated this is due to the intracellular phosphorylation of Osterix protein・
Therefore, Phosphatase treatment of Osx-WT and Osx-ZFI was perfomed in vitro・ Only
the mutant form ZFI was used as a comparison against WT because it is the shortest
mutant, and ifit shows any changes, ZF2 and ZF3 1ikely will as well. Figure 6 clearly
demonstrated that reduction ofbands was observed by the phosphatase treatment on the
Osx-WT and -ZF l , indicating the presence ofphosphorylated form of Osx and
Phosphorylated site(S) are likely located at amino acid positions l -293.
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1　2　3　4　5　6
IP: Anti-Flag (M2 Gel)
WB: Anti-FLAG
Fi貿ure 6: Phosphatase Treatment ofOsx-WT and Osx-ZFl
(A) Demonstrates the results oftreating the Osx protein with phosphatase. The lanes
With a (-) are control lanes that were left untreated, While the (+) lanes were the
experimental lanes. In both the samples where Osx-WT and Osx- ZF=anes were
OVereXPreSSed (Lanes 3-6), the treated lanes (Lanes 4 and 6) both show one less band
than the untreated lanes (Lanes 3 and 5), thereby verifying that phosphate was removed
from the protein, and decreased the apparent molecular weight.
2与
(B) The entire membrane with marker lanes on the left and right.
4.5 Generation ofthe Osx-K41R Mutant Form
It has been shown that human Osterix likely has a post-tranSlational modification
on the lysine (K) residue at position 41 according to the Phosphosite
(ww.phosphosite.org). In order to investigate whether K41 undergoes a post-
translational modification, PCR was completed using custom prlmerS tO Create a neW
“K41R,, mutant fom using the previous wild type and ZFl foms ofOsterix (Figures 7 &
8). This K41R mutant is a version ofthe protein that instead ofhaving a lysine-41 will
have an argmme, Which is not ubiquitinated/acetylated・ This will allow for us to check
for a change in mobility ofthe Osterix protein after Westem blotting or identfty any
differences in band pattems (Figure 9)・
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旦isure 7: Generation of Osx-K41R By PCR Reaction
This diagram explains how血e two point mutations to convert the lysine to argmme Were
made. Strands l and 2 were created individually, and血en joined in the last PCR step.
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Figure 8: ElectroDhoresis ofK41R PCR Products
潮干　芝印
‾‾　　　　　　　　　臆臆臆臆臆臆臆
Hi Lo Hi Lo
1　芝　3　4
(A) Shows that the final step ofthe two PCR reactions shown in Figure 7 created one
Single, COrreCtly sized product. As like before, the reaction was divided into a high and
low prlmer amOunt trial, but both were successful.
(B) Shows the entire gel with the marker lane on the left. Lanes l and 2 show the attempt
to create a WT-K41R mutant but was unsuccessful at this step.
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Figure 9: Generation of ZFl-K41R Mutant Form
The plasmids were collected from the coIonies and digested with EcroRT/XhoI prior to
separation by electrophoresis gel. The gel image showed the success餌isolation ofthe
ZFl-K41R plasmid after it was purified from coIony待C" ofJMlO9 cells and verified by
the restriction enzyme digestion. The dense bands at the top ofthe gel (at -5500 bp) are
the rest ofthe vector that the insert was digested from.
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1　　2　　3　　4　　5
IP: Anti-Flag (M2 Gel)
WB: Anti-FLAG
B. ZF宣_K41R
EV ZFI K41R
十　　　_　　十
1　2　3　4　5
Figure lO: Phosphatase Tr tment ofOsx-ZFl and Osx-ZFl_K41R Protein Forms
(A) This figure shows the expression pattem of Osx-ZFl and Osx-ZFl -K41R forms in
the presence or absence ofphosphatase. The負-,, lanes are untreated, and the “十・, lanes
have received the phosphatase treatment・ Despite the phosphatase treatment, lanes 3 and
5 still show the apparent low-Weight third band.
(B) This image shows the membrane in its entirety, With marker lanes on the right and
le蹄.
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Xh劇場Osx-新種諸∴∴∴∴ C丁辱章毎鰯駐AGÅA竜
織※車K埠鼻穴場民 CTTTGTG CCTG CCC
Figure ll: Table ofAll Primers Used In the Present Stud
丁‡鵜舟葛篭亀
書きCA鰯Å鋸丁
In the left column are the names created to identify all the prlmerS, the column on the
right contains the exact sequence for each primer listed in the 5’to 3’direction.
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Figure 12: Protein Sequence of Osx-ZFI With Known and Possib萱e Sites for
PhosDhorvlation
(A) Shows the protein sequence of Osx-ZF l , With documented phosphorylation red
arrows, aS Per Phosphosite.org. The lysine-4 1 acetylation (according to
WWW.Phosphosite.org) site is indicated by the puaple arrow. The green arrows indicate
all the potential sites for phosphorylation血at are available in血e Osx-ZF I protein・
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5. Discussion:
Osterix is a zinc finger transcription factor that is critical for the differentiation of
mesenchymal precursor cells into osteoblasts and osteocytes・ The DNA binding domain
of Osterix is Iocated at its three C2H2-tyPe Zinc fingers at the C teminus. Osterix binds
to spl and EKLF consensus sequences as well as other G/C rich areas, Which are found
in many promoters (Nakashima, Zhou et al. 2002).
It has been demonstrated that in the absence ofOsterix, nO bone fomation wi11
occur aYakashima, Zhou et al. 2002; Ortuno, Ruiz-Gaspa et al. 2010)・ With no
expression of Osterix’nO COrtical bone and no trabeculation are fomed via either
intramembranous or endochondral ossification process. Nomally during endochondral
ossification, the degradation of the mineralized cartilage matrix is handled by
osteoclasts/chondroclasts and subsequently replaced by bone matrix from osteoblasts・ In
Osterix null mutants, Chondroblasts still develop and penetrate the cartilage matrix, but
there are no osteoblasts present・ This phenotype may be due to the inability ofOsterix to
induce VEGF expression which is a crucial growih factor for angiogenesis (Tang, Yang
etaL 201言).
As mentioned previously, Osterix possesses the three C2H2rtype zinc fingers at
its C terminus. This 85 amino acid zinc finger motif is very similar to that ofthe
transcription factors Spl , Sp3, and Sp4, and to somewhat lesser degree transcription
factors ofthe Kruppel-1ike family oftranscription factors. This structural similarity leads
us to the beliefthat Osterix itself acts as a transcription factor, and that this controI of
DNA transcription may in fact be how it exerts its important regulation on osteoblast
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function and differentiation. Additionally, uPStream tO the zinc finger region in Osterix is
a segment ofbasic amino acids that resemble a reglOn OfEGR-1 that has previously been
demonstrated to be important for nuclear localization OVakashima, Zhou et al・ 2002)・
Despite the knowledge that Osterix plays a critical role in osteogenesis, the
precise mechanism as to how it is regulated is not well known. Extracellular mediators
such as growth factors, CytOkines, mitogens and homones all interact with different
receptors such as: reCePtOr tyrOSine kinases (RTKs), G protein-COuPled receptors
(GPCRs) and epidemal growth factor receptors (EGFR). MAPKs can phosphorylate
many target substrates as Iong as they possess a serine or threonine residue fo11owed by a
proline residue. Through this phosphorylation, a MAPK can regulate ce皿ar activities
such as gene expression’mitosis, embryogenesis, Cell differentiation, mOVement,
metabolism, and apoptosis. Two such types ofMAPK are ca11ed the extrace11ular-Signal-
regulated kinase l/2 (Erk l/2) and p38・ Studies have shown that Erk/MAP Kinases can
be regulated by extracellular signals such as FGF and BMP, and extracellular matrix, a11
of which can stimulate osteoblast di節erentiation. Additionally, Erk/MAP kinases
stabilize Runx2, Which acts as the upstream transcription factor for Osterix・ It has also
been shown that Erk l/2 help to regulate the osteogenic e節ects of Osterix by increasmg
the protein stability and transcription activity during the di節erentiation of osteoblasts. It
has also been shown that the phosphorylation of Osterix by Erk l/2 not only enhances the
transcriptional ability of Osterix, but lengthens the halfLlife as well (Choi, Gu et al. 201 1).
Erkl/2 signaling may also regulate the phosphorylation, ubiquitination, and acetylation
through post-tranSlational modifications. Though what other kinases are acting upon
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Osterix is not well understood, it is clear that post-tranSlational modification via
phosphorylation is an important regulator of Osterix (Choi, Gu et al. 201 1)・
The餌1-length wild type Osterix protein has an estimated molecular weight of
-46 kDa based on its 431 amino acid residues・ According to our Westem blotting data,
as shown in Figure 5, Wild type Osterix is actually shown to be approximately 60 kDa
(Lane 2). This increase of its molecular weight demonstrated in the present study is
likely due to the post-tranSlational modifications that occur intrace11u]arly. When an
amino acid residue is modified by a kinase and phosphorylated’the net change in mass is
-80 Da. According to the Phosphosite website (WWW.Phosphosite.org), Wild type Osterix
has 14 documented Serine/Threonine sites that are known to be phosphorylated on
Osterix based on global mass spectrometric studies. This would allow for a maximal
increase in molecular weight ofup to l.1 kDa. While this small increase in mass likely
cannot account for the 14 kDa increase from the predicted weight of Osterix, it can
potentially explain the subtle separation ofthe uppermost band that appears in all of our
Westem blots of Osterix from the middle band during this experiment, aS Seen in Figures
5,6,and7.
In the current study, all foms ofOsterix that were used presented with 2 or 3
bands demonstrated by Westem blotting fo11owed by immunoprecipitation. Figure 5
shows an example ofthe triple bands, and Figure 6 shows just double band formations.
In our laboratory, this experiment was partia11y completed last year by the previous
student Dr. Morcos when he initiated this experiment and also developed the Osx-ZF3
3与
mutant that was used. Triple bands were also observed by the Westem blots by Dr.
Morcos, demonstrating the reproducibility of the cuITent reSults.
As stated above, in all Westem blots during this experiment there is always an
upper band and a bottom band with a miniscule distance between them, the only
exception being the occasional fomation of a third, lighter, band with approximately the
same amount of separation・ This small distance may be related to the l.1 kDa difference
associated with phosphorylation ofthe protein. This l.1 kDa separation appears to be
consistently visible in all the mutant foms, but this is misleading. The mutant Osx-ZF3
deletes the third zinc finger and so the following downstream sites of phosphorylation
based on Phosphosite data are also deleted: T375, S396, T397, S41 1, S422’and S426.
This removes six ofthe available 14 sites for phosphorylation’1eaving a maximum of 8
known phosphorylation sites. 8 phosphorylation sites could at most provide a separation
ofthe bands conesponding to 640 Da’nearly halfthe original weight’indicating the
presence of additional phosphorylation sites yet uniden舶ed・
We observed that there is an exponential increase in separation ofbands as they
move down the SDS-PAGE gel・ An example ofthis would be Figure 5, lane 2 vs lane 5.
Lane 2 has three bands with a just barely discemible spacing between them, Whereas lane
5 shows three clearly distinct bands・ Considering that the molecular weight of Osx-WT
is significantly higher than that of Osx-ZF l’this explains why the wild type banding
pattem often looks clumped together as one large band and the ZFl bands are much more
distinguished from each other. This may be due to the resolution range of4-12% SDS-
PAGE used in the present study. As a result, eVen though the Osx-ZFl mutant fom
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should show less separation between the uppermost two bands than in Osx-WT or Osx-
ZF3, due to this expansion effect, it appears the same or greater in comparison.
The lowest weight band ofthe three bands that appears in Figure 5, does not seem
to show up consistently enough to predict its appearance. Using the separation ofthe
upper two bands as a guide for -1 kDa we can extrapolate that the bottom two bands may
also be -1 kDa apart. From the results ofFigure 5, We Can COnClude that the location of
the upper, Phosphorylated, band consistently shows similar mobility in each Westem blot
figures as well. Using this’ifwe look at Osx-ZFl, the upper band is always at -43 kDa
and the de-Phosphorylated band is -42 kDa as shown in Figure 6. Using the 42 kDa and
43 kDa bands as landmarks in Figure 5, this implies that there is post-tranSlational
modification occurrmg SOmeWhere that is resulting in a third’lowest’band that is not
related to phosphorylation and must decrease its mobility’Creating a band of
approximately -41 kDa. It is possible that this band may always be present but since it is
in lower concentration, it is not always visible by Westem blotting. This is especially the
case when the SDS-PAGE gel separation step is not run until the lowest marker bands
reach the absolute bottom ofthe gel. This results in the bands stacking on top ofeach
other and present as only one or maybe two bands. This concept is evident in that the
Osx-WT at first glance always seems to present with one very large, dense, band. In
reality, if one looks cIosely’One Can detect the outline oftwo distinct bands that are
merely very cIose to each other, tO the point ofoverlappmg. This possibility ofan
overlapplng effect also a11ows for another possible explanation・ It is possible that the
Osterix protein always presents as a pair ofbands separated by -1 kDa, a base band and a
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phosphorylated band. Ifwe accept that there is always a pair ofbands but that sometimes
a percentage of the Osterix lacks some unknown modification that removes
approximately l kDa from the molecular weight ofboth bands’this could shift their
position downwards on the gel by -1 kDa. This shift would make the base band from the
modified, heavier, Palr OVerlap with the phosphorylated band from the unmod輔ed’
lighter, Pair, thus creating the visual impression ofthree bands・ Lane 5 ofFigure 5 is the
clearest example ofthe “middle” band being the darkest, POtentially due to the doubling
effect ofhaving two bands stacked on top of one another. Additiona11y, in Figure lO,
1anes 2 and 4 show a blurring effect where there should be three distinct bands,
potentially showing a misalignment ofthe two palrS and revealing a larger overall band
pattem・ It is not feasible that cleavage ofsome portion ofthe protein is the cause ofthe
third band because the protein is tagged and visualized by the FLAG tag at the N
teminus・ If cleavage occurred, and we are able to visualize the FLAG tagged portion of
the proteins, it would result in identically sized proteins, and would get one identical band
pattem in every untreated lane. The differently sized remainders ofthe proteins would be
lost during the antibody treatments that would ignore these fragments. Lastly’although
unlikely, it is a possibility that the third band could potentially be a result of handling
error, Pethaps indicating that some segment or mo棚cation ofthe protein is fragile and
degrades at room temperature or during agitation.
It was stated earlier that the estimated weight ofwild type Osterix is -46 kDa yet
in all Westem blots from this experiment, it presents as -60 kDa・ Osx-ZF3 should weigh
-43 kDa but weighs -50 kDa. ZF2 predicted weight is - 38 kDa and presents as 43 kDa・
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Lastly, ZFl is predicted to be -35 kDa but according to Figure 5 weighs - 40 kDa. The
di節erences of actual weights to predicted weights from longest fom to shortest fom are
as follows: 14, 7, 5, and 5 kDa. It would make sense that the di節erence from Osx-WT to
Osx-ZF3 would be the greatest since nearly halfthe phosphorylation sites are
downstream to the third zinc finger that is removed, and nearly halfthe weight・ The delta
value for ZF3 and ZF2 to decrease from 7 to 5 does not correspond to a loss of
Phosphorylation sites. It is a sma11 value and may be due to measurement error or it may
be due to some other unforeseen site ofpost-tranSlational modification being removed.
The remammg COnSistent delta value of5 kDa cannot be explained by a mere 7 remalnmg
Sites ofpossible phosphorylation, aS Per WWW.Phosphosite.org. Since there are other
POtential sites for phosphorylation (Figure 12), it is possible that there are undocumented
Phosphorylations that have occurred・ Therefore, based on this calculation, there appears
7 kDa post-tranSlational modification at the position from 349 to 43 1 (COrreSPOnding to
the ZF3 region), 2 kDa at the position from 319 to 348 (ZF2 region), nO mOd純cation at
positions from 294 to 318 (ZFl region) and 5 kDa at the position from l to 293. Another
likely candidate for this additional mass is the lysine-41 that was iden舶ed by
Phosphosite, eVen in Osx-ZFl. This lysine’ifmono-ubiquitinated, WOuld add 8.5 kDa of
mass to all foms ofOsterix, and could explain the higher mass values (Haglund and
Dikic 2005).
To investigate if lysine-41 is post-tranSlationally modified’a neW mutant fom of
Osx-ZF I ca11ed Osx-ZFl-K41R was created. As stated earlier, and explained graphica11y
in Figure 7, the lysine-41 was mutated into an arginine for the puxpose of investigating
39
this lysine modification, POtentially being ubiquitination・ Figure lO shows that the
molecular weights of Osx-ZF l and Osx-ZF l -K41R are exactly the same. This similarity
in weight between ZFl and K41R leads us to believe that lysine mod描cation is not
playing a part in the weight sh紐from the predicted values・ It is important to note,
however, that the cel1 1ine used for this experiment is derived from kidney cells and not
ofJJN3, multiple myeloma cel1 1ine. Due to the cells different cells used in the
Phosphosite proteomics study, it is possible that the post-tranSlational modification may
be slightly different and specific to the cells used.
It would be recommended in the future to repeat this experiment agam With a
different lineage ofce11s to confim the results found in Figure lO’ideally in osteoblasts.
Altemative approaches to investigate this further might be to perform Westem blot
analysis fo11owed by but immuno-PreCipitation with anti-Ubiquitin antibody to identify if
using the 293 kidney cells is the problem, and whether ubiquitin is even present. There
are also other types ofmodifications that may be occumng On the lysine-41, SuCh as
acetylation, Which might be detected by Westem blot analysis with anti-aCetylated lysine
antibody. The presence of small ubiquitin-1ike modifier-1 (SUMO-1) may also be
present on lysine-41, Or eVen On Other lysines・ SUMO-1 is a modification oflysine that is
hypothesized to stabilize proteins by blocking the attachment of ubiquitin (Sampson,
Wang et al. 2001).
In summary, this study confimed that the Osterix protein is phosphorylated, and
that several ofthose sites occur on the N-teminus side ofthe first zinc finger.
Additionally, We leamed that ubiquitination does not seem to play a role in either the
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triple banding or the higher than predicted molecular weight with regards to lysine-41
when expressed in 293 kidney cells. As mentioned earlier, uSe Of anti-ubiquitin or anti-
acetylated lysine antibody would provide additional infomation. Another potential
method would be to analyze the protein through proteomics. Due to the significant level
of control that Osterix has over bone fomation, it is highly advisable that we continue to
investigate the nature of this protein and how its post-tranSlational modifications affect its
functions.
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